Chinese Medicine Combined With EGFR-TKIs Prolongs Progression-Free Survival and Overall Survival of Non-small Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations, Compared With the Use of TKIs Alone

Chinese Medicine Combined With EGFR-TKIs Prolongs Progression-Free Survival and Overall Survival of Non-small Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations, Compared With the Use of TKIs Alone

Objective: To explore the efficacy comparison between epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR-TKIs) combined with traditional Chinese medicine (TCM) and single EGFR-TKIs for advanced non-small cell lung cancer (NSCLC).Methods: A total of 91 NSCLC patients with EGFR mutation...

Full description

Bibliographic Details
Main Authors: Yujia Wang, Guoyu Wu, Ru Li, Yingzhe Luo, Xingmei Huang, Lifang He, Huihui Zhong, Shaoquan Xiong
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Public Health
Subjects:
traditional Chinese medicine
non-small cell lung cancer
progression-free survival
overall survival
cohort study
disease control rate
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2021.677862/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2021.677862/full

Similar Items